Silvant Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $84K | Hold |
1,169
| – | – | ﹤0.01% | 246 |
|
|
2025
Q4 | $92.8K | Hold |
1,169
| – | – | ﹤0.01% | 232 |
|
|
2025
Q3 | $88.1K | Hold |
1,169
| – | – | ﹤0.01% | 235 |
|
|
2025
Q2 | $80.6K | Hold |
1,169
| – | – | ﹤0.01% | 234 |
|
|
2025
Q1 | $79.2K | Hold |
1,169
| – | – | ﹤0.01% | 234 |
|
|
2024
Q4 | $52.5K | Hold |
1,169
| – | – | ﹤0.01% | 266 |
|
|
2024
Q3 | $73.5K | Hold |
1,169
| – | – | ﹤0.01% | 246 |
|
|
2024
Q2 | $69K | Hold |
1,169
| – | – | ﹤0.01% | 241 |
|
|
2024
Q1 | $93.2K | Sell |
1,169
-31,158
| -96% | -$2.38M | ﹤0.01% | 225 |
|
|
2023
Q4 | $2.55M | Sell |
32,327
-73
| -0.2% | -$5.2K | 0.14% | 99 |
|
|
2023
Q3 | $2.26M | Hold |
32,400
| – | – | 0.14% | 99 |
|
|
2023
Q2 | $2.24M | Sell |
32,400
-13
| -0% | -$925 | 0.13% | 105 |
|
|
2023
Q1 | $2.41M | Hold |
32,413
| – | – | 0.16% | 99 |
|
|
2022
Q4 | $3.02M | Sell |
32,413
-79
| -0.2% | -$7.62K | 0.21% | 90 |
|
|
2022
Q3 | $3.1M | Sell |
32,492
-300
| -0.9% | -$29.7K | 0.21% | 83 |
|
|
2022
Q2 | $3.04M | Sell |
32,792
-478
| -1% | -$46.7K | 0.74% | 30 |
|
|
2022
Q1 | $3.37M | Sell |
33,270
-852
| -2% | -$89.5K | 0.64% | 35 |
|
|
2021
Q4 | $3.52M | Sell |
34,122
-1,877
| -5% | -$173K | 0.6% | 40 |
|
|
2021
Q3 | $3.06M | Sell |
35,999
-3,493
| -9% | -$293K | 0.55% | 44 |
|
|
2021
Q2 | $3.29M | Sell |
39,492
-1,035
| -3% | -$84.8K | 0.52% | 48 |
|
|
2021
Q1 | $3.05M | Hold |
40,527
| – | – | 0.52% | 49 |
|
|
2020
Q4 | $2.77M | Sell |
40,527
-223
| -0.5% | -$14.5K | 0.47% | 55 |
|
|
2020
Q3 | $2.38M | Sell |
40,750
-690
| -2% | -$42.9K | 0.45% | 58 |
|
|
2020
Q2 | $2.69M | Buy |
41,440
+598
| +1% | +$37.7K | 0.48% | 50 |
|
|
2020
Q1 | $2.42M | Buy |
40,842
+8,430
| +26% | +$563K | 0.53% | 51 |
|
|
2019
Q4 | $2.41M | Sell |
32,412
-200
| -0.6% | -$14K | 0.44% | 66 |
|
|
2019
Q3 | $2.06M | Sell |
32,612
-125
| -0.4% | -$7.41K | 0.41% | 69 |
|
|
2019
Q2 | $1.78M | Sell |
32,737
-312
| -0.9% | -$16.8K | 0.32% | 81 |
|
|
2019
Q1 | $1.78M | Buy |
33,049
+268
| +0.8% | +$16.5K | 0.32% | 82 |
|
|
2018
Q4 | $2.15M | Sell |
32,781
-20,764
| -39% | -$1.55M | 0.43% | 77 |
|
|
2018
Q3 | $4.21M | Buy |
53,545
+49,028
| +1,085% | +$3.51M | 0.52% | 67 |
|
|
2018
Q2 | $291K | Buy |
4,517
+4,306
| +2,041% | +$284K | 0.04% | 166 |
|
|
2018
Q1 | $13K | Buy |
+211
| New | +$15.1K | ﹤0.01% | 323 |
|
Other funds holding CVS
VCM
VPM
Silvant Capital Management's CVS Position: Q1 2026 in Review
Silvant Capital Management held its CVS Health (CVS) position steady in Q1 2026 at 1,169 shares worth $84K. The position accounts for ﹤0.01% of the portfolio, ranked #246.
Silvant Capital Management first reported a position in CVS in Q1 2018 and has held it in 33 quarters since. The position peaked at $4.21M in Q3 2018. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Silvant Capital Management held 1,169 shares of CVS Health worth $84K as of Q1 2026.
- Silvant Capital Management left its CVS Health share count unchanged in Q1 2026.
- CVS Health made up ﹤0.01% of Silvant Capital Management's portfolio in Q1 2026, its #246 holding.
- Silvant Capital Management first reported a position in CVS Health in Q1 2018 and has held it in 33 quarters since.
- Silvant Capital Management's CVS Health position peaked at $4.21M in Q3 2018.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.